ASCO GI 2023 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO GI 2023 Conference Coverage

Videos

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Phase 3 Randomized SUNLIGHT Study: Trifluridine/Tipiracil + Bevacizumab for 3L Treatment of Refractory mCRC

By ASCO GI 2023 Conference Coverage FEATURING Josep Tabernero

0 views

January 25, 2023

Disclaimer: This video was recorded prior to FDA approval of trifluridine and tipiracil with bevacizumab ...
read more ↘ on August 2, 2023 for mCRC.
↖ read less

Comments 0

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Videos